Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.5 million individuals worldwide. Through its network of 3,335 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for 280.942 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS).
|Factsheet (PDF, 0.2 MB)|
- Institutional Investor: Best IR in Healthcare
- Institutional Investor: Oliver Maier best IR Professional in Healthcare
- red dot award: Online Annual Report "Continuity"
- Thomson Reuters: best Company in IR MedTech&Services